Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL536037 | 0.66 | ADORA3 (0.34) | ALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL28836033 | 0.59 | MEN1 (0.35) | MEN1ALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL28835979 | 0.57 | CYP1A2 (0.32) | MEN1ALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL6118859 | 0.57 | KDM4E (0.49) | ALDH1A1GAAMAPTHPGD | |
| SCHEMBL6118855 | 0.57 | KDM4E (0.55) | ALDH1A1GAAMAPTHPGD | |
| SCHEMBL28835982 | 0.57 | MEN1 (0.33) | MEN1ALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL28835983 | 0.57 | MEN1 (0.35) | MEN1ALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL6119213 | 0.56 | CFTR (0.54) | ALDH1A1GAAMAPTHPGD | |
| SCHEMBL12731290 | 0.55 | KDM4E (0.43) | ALDH1A1GAAMAPTHPGD | |
| SCHEMBL6811268 | 0.55 | ALDH1A1 (0.52) | MEN1ALDH1A1GAAMAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2414328-A2 | DIHYDROOROTATE DEHYDROGENASE INHIBITORS | Merck Serono S.A. (CH) | 2012-02-08 | — | — | EP | disclosed |
| WO-2010115736-A2 | DIHYDROOROTATE DEHYDROGENASE INHIBITORS | MERCK SERONO S.A. (CH) | 2010-10-14 | — | — | WO | disclosed |